January 22, 2020
The identification of a novel coronavirus in Wuhan, China, earlier this month, that has since been diagnosed among travelers from the central China city to other Asian countries, and to a patient in Washington state, has led to public health screening at select United States airports.
Read More
The IDSA Clinical Fellows Meeting for Infectious Diseases, held Jan. 16-18 in Naples, Florida, attracted nearly 100 fellows representing 95 infectious diseases training programs.
Read More
As a new year of promoting IDSA and HIVMA priorities begins, here’s how your voice made a difference during the past year in advancing public policies that combat antimicrobial resistance, aim to end the HIV epidemic, improve patient care, secure the future of the ID/HIV workforce, and boost federal prevention, research and public health programs.
Read More
In this feature, a panel of IDSA members identifies and critiques important new studies in the current literature that have a significant impact on the practice of infectious diseases medicine.
Intravenous Fosfomycin for Complicated Urinary Tract Infections and Plazomicin for Complicated Urinary Tract Infections: A Once-Daily Option
Read More
IDSA, SHEA and PIDS are pleased to announce that applications for the 2020-2021 Leaders in Epidemiology, Antimicrobial Stewardship and Public Health (LEAP) Fellowship are now open.
Read More
Congress passed the Laboratory Access for Beneficiaries (LAB) Act as part of its end-of-year federal spending package.
Read More
The Department of Health and Human Services Tickborne Disease Working Group has produced three topic briefs through HHS researchers and is preparing to have subcommittees report their findings and recommendations at an upcoming meeting.
Read More
When a pneumonia-like illness was recently discovered in a series of patients and linked to visits to a seafood market in the transportation hub Wuhan City in the People’s Republic of China, IDSA Global Health Committee member Daniel Lucey, M.D., MPH, FIDSA was on the story for IDSA.
Read More
The recent outbreak of a novel coronavirus in China has captured the attention of health authorities and the public. With moment to moment developments in the outbreak, IDSA issued an expert alert to media, offering our spokespersons for interviews.
Read More